To Study the Effect of Katankateryadi Ghanavati in treating Madhumeha (Diabetes Mellitus )

Randomised controlled trial to study the effect of katankateryadi ghanavati in the management of madhumeha With special reference to Diabetes Mellitus. - nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/06/088161

Enrollment

Registered

2025-06-03

Start date

Unknown

Completion date

Unknown

Last updated

2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Katankateryadi Ghanavati: Daruharidra 1part Madhuyashti 1Part Chitraka 1Part Haritaki 1Part Bibhitaka 1Part Amalki 1Part Reference : Chaktadatta Prameha Chikitsa 19 , Route : Oral , Dos

Eligibility

Inclusion criteria

Inclusion criteria: patients having fasting blood sugar level between 126mg/dl to 225mg/dl , Post Prandial 200mg/dl to 300mg/dl & HbA1c 6to 8

Exclusion criteria

Exclusion criteria: patient under treatment with insulin, alpha glucosidase inhibitors ,thiazolidonediones ,DPP4 Inhibitors, SGLT2 Inhibitors, and steroid treatment. pregnant woman and lactating mothers . having complications like DKA ,NKHS ,Neuropathy and septicemia.

Design outcomes

Primary

Measure	Time frame
reduce the sign and symptoms of madhumeha, also reduction in blood sugar level.Timepoint: 90 days	—

Secondary

Measure	Time frame
Where trail group stands in comparison with control group in reducing signs and symptoms of Diabetes MellitusTimepoint: 18 months	—

Countries

India

Contacts

Public ContactPournima Kadam

shree saptashrungi ayurved mahavidyalaya,nashik

drpvjagtap@gmail.com9822852144

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026